Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 2, 2017
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical centerJeff A Engle, Anne M Traynor, Toby C Campbell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2024
Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcomeOjaswita Lokre, Timothy G Perk, Amy J Weisman, et al.
Medical Oncology (Northwood, London, England)|February 8, 2011
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802Naomi B Haas, Xinyi Lin, Judith Manola, et al.
Cancer Investigation|November 5, 2015
A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid MalignanciesSam Joseph Lubner, Jacqueline Mullvain, Scott Perlman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancerGlenn Liu, George Wilding, Mary Jane Staab, et al.
Cancer|August 28, 2009
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 ConsortiumDeborah Bradley, Dana Rathkopf, Rodney Dunn, et al.
Investigational New Drugs|December 23, 2016
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumorsChristos E Kyriakopoulos, Amy M Braden, Jill M Kolesar, et al.
Urologic Oncology|July 26, 2011
Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancerGlenn Liu, Yu-Hui Chen, Jill Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative studyAlejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast CancerKari B Wisinski, Amye J Tevaarwerk, Mark E Burkard, et al.
Pageof 13